Marta Rodríguez Moreno

Marta Rodríguez Moreno is a Molecular Biologist who obtained her PhD in Dr. Félix Bonilla’s laboratory at the Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (Madrid, Spain), analyzing the critical role of extracellular vesicles during tumorigenesis in breast cancer and colorectal cancer ( Silva J, García V, Rodríguez M et al. Genes Chromosomes Cancer., 51(4):409-18, (2012); Soldevilla B, Rodríguez M et al. Hum Mol Genet., 15:23(2):467-78 (2014); Rodríguez M et al. Oncotarget., 1:6(38):40575-87 (2015)). During her PhD, she was the beneficiary of a short-term research fellowship at Dr. Edit Buzás´s lab (Semmelweis University, Budapest, Hungary) in 2015 as FPI to learn specific approaches about exosomes, metastasis and pancreatic cancer (Osteikoetxea X, Benke M, Rodriguez M et al. Biochem Biophys Res Commun., 30:499(1):37-43, (2018)). In 2016, she joined Dr. Alicia Llorente´s laboratory (Oslo University Hospital, Institute for Cancer Research, Oslo, Norway) as a postdoctoral fellow to understand the extracellular vesicles molecular cargo as potential biomarkers in prostate cancer (Rodríguez M et al. Mol Cancer., 5:16(1):156, (2017); Endzeliņš E, Berger A, Melne V, Bajo-Santos C, Soboļevska K, Ābols A, Rodriguez M et al. BMC Cancer., 9;17(1):730, (2017)). Marta is currently a postdoctoral researcher in Dr. Miguel Ángel Piris´s lab at the Instituto de Investigación Sanitaria-Fundación Jiménez Díaz (Madrid, Spain). The group is focused on complex lymphoproliferative diseases characterized by clinical aggressiveness with low therapeutic response, tumour heterogeneity and patterns of dependency/interaction with the microenvironment. She is part of Haematological Tumours Group and the Liquid Biopsy working module team of the CIBERONC network.